3,4-Methylenedioxy-N-methylphentermine

3,4-Methylenedioxy-N-methylphentermine (MDMP or 3,4-methylenedioxy-α,α,N-trimethylphenethylamine) is a lesser-known psychedelic drug. MDMP was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 110 mg, and the duration is listed as approximately 6 hours.^[1] MDMP produces few to no effects, and is slightly similar to MDMA. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMP.

MDMP

Names
Preferred IUPAC name 1-(2H-1,3-Benzodioxol-5-yl)-N,2-dimethylpropan-2-amine
Identifiers
CAS Number	81262-69-3
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL347779
ChemSpider	21106335
PubChem CID	44366836
UNII	P556669V7S
CompTox Dashboard (EPA)	DTXSID10658475
InChI InChI=1S/C12H17NO2/c1-12(2,13-3)7-9-4-5-10-11(6-9)15-8-14-10/h4-6,13H,7-8H2,1-3H3 Key: CRFWCCGPRXKZSM-UHFFFAOYSA-N
SMILES CC(C)(NC)Cc1ccc2OCOc2c1
Properties
Chemical formula	C12H17NO2
Molar mass	207.273 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.^[2]

See also

• Phenethylamine
• Psychedelics, dissociatives and deliriants